TScan Therapeutics, Inc. (TCRX)

TScan Therapeutics Revenue

TScan Therapeutics had revenue of $3.08M in the quarter ending June 30, 2025, with 473.88% growth. This brings the company's revenue in the last twelve months to $6.96M, down -42.94% year-over-year. In the year 2024, TScan Therapeutics had annual revenue of $2.82M, down -86.62%.

• Revenue (ttm): $6.96M
• Revenue Growth: -42.94%
• P/S Ratio: 13.04
• Revenue / Employee: $35,697
• Employees: 195
• Market Cap: 90.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.82M	-18.23M	-86.62%
Dec 31, 2023	21.05M	7.51M	55.52%
Dec 31, 2022	13.54M	3.39M	33.47%
Dec 31, 2021	10.14M	9.06M	834.65%
Dec 31, 2020	1.09M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.